58% of Americans now have a mobile phone with web connectivity.
10% of online consumers said they purchase online from their mobile device, 16% compare prices and another 16% research product details/specifications. Of the online consumers making purchases from their mobile phones, 58% have purchased digital content for their phone, 51% have purchased consumer electronics, 37% have purchased computers, 36% have purchased books, and 31% have purchased clothing. Smartphone and iPhone owners are comfortable using the mobile Internet to make purchases. 56% of Apple iPhone owners and 28% of smartphone owners already are comparing prices online with their mobile phones. Additionally, 27% of iPhone owners and 35% of smartphone owners anticipate that they will be comparing prices within two years. Source: http://www.itfacts.biz/58-of-americans-have-a-mobile-phone-with-web-connectivity/12965
58% of online consumers currently own a mobile phone capable of connecting to the Web. Of the online consumers with Web-enabled phones, 21% own a smartphone, 8% own an iPhone(TM), and 29% own another type of Web-enabled phone. 42% of PriceGrabber survey respondents said they own a non-Web-enabled phone capable of using voice and text service plans only. iPhone, released on June 29, 2007, jump-started mainstream smartphone adoption, with 75% more online consumers purchasing their first Web-enabled phone in 2007 compared with 2006. Despite the economic climate, 8% of online consumers purchased their first Web-enabled phone in Q1 2009.
Exco InTouch
LATEST NEWS AND EVENTS
Cell phone web connectivity is on the rise
Secure and regulatory compliant mobile solutions automatically schedule and deliver text messages directly to patients and caregivers.
The world's first validated eDiary solution on a mobile phone. Secure, smarter and easier to gather crucial PRO data.
A simpler, more efficient way to gather data from subjects, care givers and sites that is fast to set up and easy to use.
Enhancing recruitment into clinical trials allows sponsor companies to reduce time and ultimately to bring new drugs to market faster.
